Treatment of Vascular and Neurodegenerative Forms of Cognitive Impairment and Dementias.
Clin Geriatr Med
; 39(1): 135-149, 2023 02.
Article
in En
| MEDLINE
| ID: mdl-36404026
ABSTRACT
Ideally, dementia care should be provided by a collaborative team. Eligible patients should be treated with the cognitive-enhancing medications, the cholinesterase inhibitors and memantine. For most of the common causes of dementia, there are no disease-modifying medications, with the exception that vascular dementia can be prevented by treating vascular risk factors to prevent stroke. There is hope that Alzheimer disease can be treated by using monoclonal antibodies that target amyloid beta, although more trials are needed. Holistic, patient-centered care can enhance quality and extend the time that the patient can live safely in the community.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Dementia, Vascular
/
Alzheimer Disease
/
Cognitive Dysfunction
Limits:
Humans
Language:
En
Journal:
Clin Geriatr Med
Journal subject:
GERIATRIA
Year:
2023
Document type:
Article
Affiliation country:
Canadá